Azenta Shares Rise Following Swing to Profit in 4Q, Sales Growth

Dow Jones11-22

By Terell Wright

Shares of Azenta advanced after the company swung to a profit and posted sales growth in the latest quarter.

Shares rose 12% to $33.51 in late morning trading on Friday, but are still down 33% this year.

The life sciences company said before the open it recorded a fourth-quarter profit of $47.1 million, or $1.02 a share, compared with a loss of $6.6 million, or 14 cents a share, in the same period a year earlier.

Adjusted earnings were 21 cents a share, beating analysts' expectations of 19 cents a share, according to FactSet.

Revenue grew 6% to $159.2 million, ahead of Wall Street's estimate of $156.2 million.

Organic revenue grew 4% driven by higher sales in the company's multiomics segment.

Chief Executive John Marotta said the company simplified its organization, made significant progress enabled by the Azenta Business System, and strengthened its execution, which drove measurable improvements in quality, delivery and productivity in fiscal 2025.

For 2026, the company expects organic revenue growth of 3% to 5%.

 

Write to Terell Wright at terell.wright@wsj.com

 

(END) Dow Jones Newswires

November 21, 2025 11:49 ET (16:49 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment